NCT06840119 2026-01-28Phase 1/2 Study of IMC-R117C in Selected Advanced CancersImmunocore LtdPhase 1/2 Recruiting600 enrolled
NCT03890952 2025-07-24Translational Study of Nivolumab in Combination With Bevacizumab for Recurrent GlioblastomaRigshospitalet, DenmarkPhase 2 Completed40 enrolled